Recombinant multi-species CCL7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes monocyte chemotactic protein 3, a secreted chemokine which attracts macrophages during inflammation and metastasis. It is a member of the C-C subfamily of chemokines which are characterized by having two adjacent cysteine residues. The protein is an in vivo substrate of matrix metalloproteinase 2, an enzyme which degrades components of the extracellular matrix. This gene is part of a cluster of C-C chemokine family members on chromosome 17q. [provided by RefSeq, Jul 2008]
The Alternative Names of target: C-C motif chemokine 7,CCL7,FIC,MARC,MCP-3,MCP3,Monocyte chemoattractant protein 3,Monocyte chemotactic protein 3 (MCP-3),NC28,SCYA6,SCYA7,Small-inducible cytokine A7
Go
to CCL7 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0072-Ag-1/ GM-Tg-hg-SE0072-Ag-2 | Human CCL7 protein | Human |
| GM-Tg-rg-SE0072-Ag-1/ GM-Tg-rg-SE0072-Ag-2 | Rat CCL7 protein | Rat |
| GM-Tg-mg-SE0072-Ag-1/ GM-Tg-mg-SE0072-Ag-2 | Mouse CCL7 protein | Mouse |
| GM-Tg-cynog-SE0072-Ag-1/ GM-Tg-cynog-SE0072-Ag-2 | Cynomolgus/Rhesus macaque CCL7 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0072-Ag-1/ GM-Tg-felg-SE0072-Ag-2 | Feline CCL7 protein | Feline |
| GM-Tg-cang-SE0072-Ag-1/ GM-Tg-cang-SE0072-Ag-2 | Canine CCL7 protein | Canine |
| GM-Tg-bovg-SE0072-Ag-1/ GM-Tg-bovg-SE0072-Ag-2 | Bovine CCL7 protein | Bovine |
| GM-Tg-equg-SE0072-Ag-1/ GM-Tg-equg-SE0072-Ag-2 | Equine CCL7 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0072-Ag-1/ GM-Tg-hg-SE0072-Ag-2;
GM-Tg-rg-SE0072-Ag-1/ GM-Tg-rg-SE0072-Ag-2;
GM-Tg-mg-SE0072-Ag-1/ GM-Tg-mg-SE0072-Ag-2; GM-Tg-cynog-SE0072-Ag-1/ GM-Tg-cynog-SE0072-Ag-2; GM-Tg-felg-SE0072-Ag-1/ GM-Tg-felg-SE0072-Ag-2; GM-Tg-cang-SE0072-Ag-1/ GM-Tg-cang-SE0072-Ag-2; GM-Tg-bovg-SE0072-Ag-1/ GM-Tg-bovg-SE0072-Ag-2; GM-Tg-equg-SE0072-Ag-1/ GM-Tg-equg-SE0072-Ag-2 |
| Products Name | CCL7 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CCL7 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.